Back to results
US 2011/0034525 A1Published application
Nonsedating alpha-2 agonists
AssigneeAllergan, Inc.
InventorsKen Chow, Todd M. Heidelbaugh, John E. Donello, Daniel W. Gil
Life of this patent
Estimating the term…
Abstract
The present invention provides an α-2A/α-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof. The present invention further provides a pharmaceutical composition that contains a pharmaceutical carrier and a therapeutically effective amount of an α-2A/α-1A selective agonist that includes a compound represented by Structure 1 or a pharmaceutically acceptable salt, ester, amide, sterioisomer or racemic mixture thereof.
Claims18
A pharmaceutical composition comprising:
- a compound represented by
- or a pharmaceutically acceptable salt thereof;
- a pharmaceutically acceptable carrier;
- and
- at least one additional component selected from the group consisting of one or more emulsifying agent, wetting agent, sweetening agent, flavoring agent, tonicity adjuster, preservative, buffer, anti-oxidant and combinations thereof.
2 more elements
Dependencies are inferred from the claim text.